24.05.2013
- Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch & Lomb from private equity owner Warburg Pincus for about $9 billion, a person...
23.05.2013
- Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the...
21.05.2013
- Royal Dutch/Shell CEO Peter Voser may be making his last appearance on the podium at the company's annual shareholder meeting on Tuesday, turning the spotlight on management's...
17.05.2013
- For Germany's chemical producers, 2013 began without the hoped-for improvement in business, but at least there was no further deterioration, the industry association Verband der...
16.05.2013
- Sweden's Recipharm has hired UBS to advise on either a partial sale of the pharmaceutical company or a listing on the Stockholm exchange, a source close to the process told Reuters...
13.05.2013
- Business - Shell Chemicals held a ground-breaking ceremony last month for the building of facilities for making high-purity ethylene oxide (HPEO) and ethoxylates at its site in...
07.05.2013
- Slower growth in the pace of U.S. healthcare spending reflects a fundamental change in the use of medical services that could save the country nearly $800 billion in the next...
28.04.2013
- A proposed merger of Valeant Pharmaceuticals International and Actavis was put on hold after the two drugmakers failed to agree on terms of a deal that would have created a...
25.04.2013
- In the first quarter 2013, Lonza's business performance was solid and in line with expectations. While the Specialty Ingredients market segment showed a good performance, the...
15.04.2013
- Life Technologies has accepted a $13.6 billion cash buyout proposal from scientific and laboratory instruments company Thermo Fisher Scientific in one of the year's biggest...
